Cisen Pharmaceutical Statistics

Total Valuation

SHA:603367 has a market cap or net worth of CNY 6.47 billion. The enterprise value is 4.03 billion.

Market Cap	6.47B
Enterprise Value	4.03B

Important Dates

The next estimated earnings date is Tuesday, April 22, 2025.

Earnings Date	Apr 22, 2025
Ex-Dividend Date	Nov 22, 2024

Share Statistics

SHA:603367 has 452.75 million shares outstanding. The number of shares has decreased by -0.06% in one year.

Current Share Class	n/a
Shares Outstanding	452.75M
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+1.67%
Owned by Insiders (%)	13.24%
Owned by Institutions (%)	5.08%
Float	169.25M

Valuation Ratios

The trailing PE ratio is 12.20.

PE Ratio	12.20
Forward PE	n/a
PS Ratio	1.52
PB Ratio	1.11
P/TBV Ratio	1.15
P/FCF Ratio	17.64
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.74, with an EV/FCF ratio of 10.99.

EV / Earnings	7.61
EV / Sales	0.95
EV / EBITDA	5.74
EV / EBIT	8.50
EV / FCF	10.99

Financial Position

The company has a current ratio of 3.19, with a Debt / Equity ratio of 0.01.

Current Ratio	3.19
Quick Ratio	2.44
Debt / Equity	0.01
Debt / EBITDA	0.11
Debt / FCF	0.22
Interest Coverage	64.47

Financial Efficiency

Return on equity (ROE) is 9.29% and return on invested capital (ROIC) is 5.05%.

Return on Equity (ROE)	9.29%
Return on Assets (ROA)	4.07%
Return on Invested Capital (ROIC)	5.05%
Return on Capital Employed (ROCE)	7.93%
Revenue Per Employee	1.25M
Profits Per Employee	155,500
Employee Count	3,402
Asset Turnover	0.58
Inventory Turnover	2.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.25% in the last 52 weeks. The beta is 0.28, so SHA:603367's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	-3.25%
50-Day Moving Average	13.49
200-Day Moving Average	13.67
Relative Strength Index (RSI)	66.70
Average Volume (20 Days)	3,435,938

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:603367 had revenue of CNY 4.25 billion and earned 529.01 million in profits. Earnings per share was 1.17.

Revenue	4.25B
Gross Profit	2.44B
Operating Income	473.47M
Pretax Income	612.69M
Net Income	529.01M
EBITDA	698.78M
EBIT	473.47M
Earnings Per Share (EPS)	1.17

Full Income Statement

Balance Sheet

The company has 2.55 billion in cash and 79.76 million in debt, giving a net cash position of 2.47 billion or 5.46 per share.

Cash & Cash Equivalents	2.55B
Total Debt	79.76M
Net Cash	2.47B
Net Cash Per Share	5.46
Equity (Book Value)	5.87B
Book Value Per Share	12.89
Working Capital	3.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 432.33 million and capital expenditures -65.82 million, giving a free cash flow of 366.50 million.

Operating Cash Flow	432.33M
Capital Expenditures	-65.82M
Free Cash Flow	366.50M
FCF Per Share	0.81

Full Cash Flow Statement

Margins

Gross margin is 57.24%, with operating and profit margins of 11.13% and 12.43%.

Gross Margin	57.24%
Operating Margin	11.13%
Pretax Margin	14.40%
Profit Margin	12.43%
EBITDA Margin	16.42%
EBIT Margin	11.13%
FCF Margin	8.61%

Dividends & Yields

This stock pays an annual dividend of 0.44, which amounts to a dividend yield of 3.09%.

Dividend Per Share	0.44
Dividend Yield	3.09%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	38.03%
Buyback Yield	0.06%
Shareholder Yield	3.15%
Earnings Yield	8.18%
FCF Yield	5.67%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:603367 has an Altman Z-Score of 4.36.

Altman Z-Score	4.36
Piotroski F-Score	n/a